Literature DB >> 9453648

Comparison of intranasal and intramuscular immunization against human immunodeficiency virus type 1 with a DNA-monophosphoryl lipid A adjuvant vaccine.

S Sasaki1, K Hamajima, J Fukushima, A Ihata, N Ishii, I Gorai, F Hirahara, H Mohri, K Okuda.   

Abstract

We compared immune responses to intranasal and intramuscular DNA vaccinations against human immunodeficiency virus type 1 with monophosphoryl lipid A (MPL) used as an adjuvant. Both routes of vaccination resulted in similar levels of cell-mediated immunity, but the intestinal secretory immunoglobulin A response was higher following intranasal immunization than after intramuscular immunization. MPL demonstrated its adjuvanticity in vaccination by both routes.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9453648      PMCID： PMC107976     

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  30 in total

1.  HIV-1-specific cell-mediated immunity is enhanced by co-inoculation of TCA3 expression plasmid with DNA vaccine.

Authors:  T Tsuji; J Fukushima; K Hamajima; N Ishii; I Aoki; H Bukawa; Y Ishigatsubo; K Tani; T Okubo; M E Dorf; K Okuda
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

Review 2.  DNA vaccines.

Authors:  J J Donnelly; J B Ulmer; J W Shiver; M A Liu
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

Review 3.  HIV type 1 vaccine-induced cytotoxic T cell responses: potential role in vaccine efficacy.

Authors:  G L Ada; M J McElrath
Journal:  AIDS Res Hum Retroviruses       Date:  1997-02-10       Impact factor: 2.205

4.  Enhancement of cell-mediated immunity against HIV-1 induced by coinnoculation of plasmid-encoded HIV-1 antigen with plasmid expressing IL-12.

Authors:  T Tsuji; K Hamajima; J Fukushima; K Q Xin; N Ishii; I Aoki; Y Ishigatsubo; K Tani; S Kawamoto; Y Nitta; J Miyazaki; W C Koff; T Okubo; K Okuda
Journal:  J Immunol       Date:  1997-04-15       Impact factor: 5.422

5.  Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization.

Authors:  N Kuklin; M Daheshia; K Karem; E Manickan; B T Rouse
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

6.  Passive transfer of local immunity to influenza virus infection by IgA antibody.

Authors:  K B Renegar; P A Small
Journal:  J Immunol       Date:  1991-03-15       Impact factor: 5.422

7.  Monophosphoryl lipid A enhances both humoral and cell-mediated immune responses to DNA vaccination against human immunodeficiency virus type 1.

Authors:  S Sasaki; T Tsuji; K Hamajima; J Fukushima; N Ishii; T Kaneko; K Q Xin; H Mohri; I Aoki; T Okubo; K Nishioka; K Okuda
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

8.  Mucosal immunogenicity of a recombinant Salmonella typhimurium-cloned heterologous antigen in the absence or presence of coexpressed cholera toxin A2 and B subunits.

Authors:  E Harokopakis; G Hajishengallis; T E Greenway; M W Russell; S M Michalek
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

9.  Immunomodulatory effects of a plasmid expressing B7-2 on human immunodeficiency virus-1-specific cell-mediated immunity induced by a plasmid encoding the viral antigen.

Authors:  T Tsuji; K Hamajima; N Ishii; I Aoki; J Fukushima; K Q Xin; S Kawamoto; S Sasaki; K Matsunaga; Y Ishigatsubo; K Tani; T Okubo; K Okuda
Journal:  Eur J Immunol       Date:  1997-03       Impact factor: 5.532

10.  Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes.

Authors:  M H Malim; J Hauber; R Fenrick; B R Cullen
Journal:  Nature       Date:  1988-09-08       Impact factor: 49.962
View more
  19 in total

Review 1.  The role of CpG in DNA vaccines.

Authors:  M J McCluskie; R D Weeratna; H L Davis
Journal:  Springer Semin Immunopathol       Date:  2000

Review 2.  Nucleic acid vaccines: tasks and tactics.

Authors:  B S McKenzie; A J Corbett; J L Brady; C M Dyer; R A Strugnell; S J Kent; D R Kramer; J S Boyle; A M Lew
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 3.  Mucosal immunity: overcoming the barrier for induction of proximal responses.

Authors:  Brent S McKenzie; Jamie L Brady; Andrew M Lew
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 4.  Synthetic DNA vaccine strategies against persistent viral infections.

Authors:  Daniel O Villarreal; Kendra T Talbott; Daniel K Choo; Devon J Shedlock; David B Weiner
Journal:  Expert Rev Vaccines       Date:  2013-05       Impact factor: 5.217

5.  Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen.

Authors:  N K Childers; K L Miller; G Tong; J C Llarena; T Greenway; J T Ulrich; S M Michalek
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 6.  Modulation of γδ T cell responses by TLR ligands.

Authors:  Daniela Wesch; Christian Peters; Hans-Heinrich Oberg; Kathrin Pietschmann; Dieter Kabelitz
Journal:  Cell Mol Life Sci       Date:  2011-05-11       Impact factor: 9.261

7.  Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates.

Authors:  M J McCluskie; C L Brazolot Millan; R A Gramzinski; H L Robinson; J C Santoro; J T Fuller; G Widera; J R Haynes; R H Purcell; H L Davis
Journal:  Mol Med       Date:  1999-05       Impact factor: 6.354

8.  Induction of systemic and mucosal immune responses to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes.

Authors:  S Sasaki; K Sumino; K Hamajima; J Fukushima; N Ishii; S Kawamoto; H Mohri; C R Kensil; K Okuda
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

9.  Nasal aluminum (oxy)hydroxide enables adsorbed antigens to induce specific systemic and mucosal immune responses.

Authors:  Haiyue Xu; Tinashe B Ruwona; Sachin G Thakkar; Yanping Chen; Mingtao Zeng; Zhengrong Cui
Journal:  Hum Vaccin Immunother       Date:  2017-09-21       Impact factor: 3.452

10.  Mucosal adjuvanticity of a Shigella invasin complex with dna-based vaccines.

Authors:  Robert W Kaminski; K Ross Turbyfill; C Chao; W M Ching; Edwin V Oaks
Journal:  Clin Vaccine Immunol       Date:  2009-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.